West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026)
West Pharmaceutical Services recorded quarterly Cash from Restructuring of $900000.0 in Q1 2026, up 12.5% quarter-over-quarter from $800000.0 in Q1 2025, and up 12.5% year-over-year from $800000.0 in Q1 2025.
West Pharmaceutical Services' Cash from Restructuring history runs 4 years deep, the most recent figure standing at $900000.0 for Q1 2026.
- In Q1 2026, Cash from Restructuring rose 12.5% year-over-year to $900000.0; the TTM figure through Mar 2026 stood at $1.7 million (up 112.5% YoY), while the FY2025 annual figure was $5.4 million, changed N/A from the prior year.
- Cash from Restructuring came in at $900000.0 for Q1 2026 at West Pharmaceutical Services, up from $800000.0 in the prior quarter.
- In the past five years, Cash from Restructuring ranged from a high of $900000.0 in Q1 2026 to a low of $800000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 900,000.00 |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2019 | 700,000.00 |
| Sep 30, 2019 | 1.20 Mn |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 300,000.00 |
| Dec 31, 2018 | 1.40 Mn |
| Sep 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 300,000.00 |
| Mar 31, 2018 | 100,000.00 |